EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 337 filers reported holding EXELIXIS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,246,000 | +16.1% | 70,658 | +16.5% | 0.01% | +14.3% |
| Q3 2019 | $1,073,000 | -40.3% | 60,638 | -27.7% | 0.01% | -46.2% |
| Q2 2019 | $1,798,000 | +18.5% | 83,820 | +32.0% | 0.01% | +8.3% |
| Q1 2019 | $1,517,000 | +45.6% | 63,510 | +21.3% | 0.01% | +33.3% |
| Q4 2018 | $1,042,000 | +8.3% | 52,377 | -3.3% | 0.01% | +12.5% |
| Q3 2018 | $962,000 | -9.1% | 54,184 | +12.2% | 0.01% | -20.0% |
| Q2 2018 | $1,058,000 | 0.0% | 48,272 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $1,058,000 | +10.1% | 48,272 | +52.7% | 0.01% | +11.1% |
| Q4 2017 | $961,000 | +49.0% | 31,612 | +18.8% | 0.01% | +28.6% |
| Q3 2017 | $645,000 | +7.0% | 26,607 | +8.7% | 0.01% | 0.0% |
| Q2 2017 | $603,000 | +22.1% | 24,469 | +7.4% | 0.01% | +16.7% |
| Q1 2017 | $494,000 | +95.3% | 22,788 | +34.1% | 0.01% | +50.0% |
| Q4 2016 | $253,000 | +0.8% | 16,987 | -13.3% | 0.00% | 0.0% |
| Q3 2016 | $251,000 | +213.8% | 19,590 | +91.5% | 0.00% | +300.0% |
| Q2 2016 | $80,000 | +175.9% | 10,229 | +39.7% | 0.00% | 0.0% |
| Q1 2016 | $29,000 | -29.3% | 7,324 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $41,000 | +5.1% | 7,324 | +6.6% | 0.00% | 0.0% |
| Q3 2015 | $39,000 | -9.3% | 6,871 | -39.6% | 0.00% | 0.0% |
| Q2 2015 | $43,000 | +48.3% | 11,371 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $29,000 | +93.3% | 11,371 | +4.6% | 0.00% | – |
| Q4 2014 | $15,000 | +200.0% | 10,871 | +229.4% | 0.00% | – |
| Q3 2014 | $5,000 | -86.1% | 3,300 | -69.2% | 0.00% | -100.0% |
| Q2 2014 | $36,000 | 0.0% | 10,700 | +4.4% | 0.00% | 0.0% |
| Q1 2014 | $36,000 | -39.0% | 10,251 | +5.7% | 0.00% | -50.0% |
| Q4 2013 | $59,000 | +90.3% | 9,700 | +83.0% | 0.00% | +100.0% |
| Q3 2013 | $31,000 | 0.0% | 5,300 | -23.2% | 0.00% | 0.0% |
| Q2 2013 | $31,000 | – | 6,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
| NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
| GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
| Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
| Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
| Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
| BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
| CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
| TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |